Varun Prabhuji | Conservative Dentistry | Best Researcher Award

Dr. Varun Prabhuji | Conservative Dentistry | Best Researcher Award

Director at Roots to Cusps Private Limited, India

Dr. Varun Prabhuji is an accomplished dental researcher and clinician with a distinguished academic background and a strong focus on advancing dental science through innovative technology. With multiple patents, trademarks, and research publications, he has made significant contributions to the field of endodontics and minimally invasive dentistry. Dr. Prabhuji’s work emphasizes the development of cutting-edge dental devices and methodologies aimed at improving patient outcomes and clinical efficiency. He is the Director of Roots to Cusps® Private Limited, where he leads efforts in dental innovation, and a Trustee of the Prabhuji Foundation, through which he supports community dental care initiatives. His research has earned him prestigious awards and substantial funding, reflecting his commitment to both academic excellence and practical advancements in dental care. Dr. Prabhuji continues to push the boundaries of dental research while fostering a vision for accessible and high-quality dental solutions.

Professional Profile

Education

Dr. Varun Prabhuji earned his Bachelor of Dental Surgery (BDS) degree from Rajiv Gandhi University of Health Sciences (RGUHS), where he consistently ranked at the top across multiple subjects. During his undergraduate studies, he received several notable accolades, including the IDA Colgate Scholarship and the ISP Merit Award. Currently, he is pursuing a Master of Dental Surgery (MDS) with a focus on advanced endodontic procedures and dental material innovations. His academic journey is marked by a commitment to excellence, with a focus on integrating advanced technology with clinical practice. Throughout his educational career, Dr. Prabhuji has demonstrated an exceptional aptitude for research, leading to the development of patented technologies and innovations. His strong academic foundation, combined with a dedication to continuous learning, positions him as a leader in the dental research community.

Professional Experience

Dr. Varun Prabhuji has amassed substantial experience in both clinical practice and research. As the Director of Roots to Cusps® Private Limited, he spearheads the development of innovative dental products, including patented technologies like PriciGuide® and PriciCrown®. His professional journey includes hands-on clinical work in advanced endodontics and the application of cutting-edge dental materials. In addition to his entrepreneurial role, Dr. Prabhuji actively contributes to the academic community through research publications and conference presentations. He also serves as a Trustee at the Prabhuji Foundation, where he oversees initiatives that provide free dental care to underserved communities. His leadership extends to organizing national and international conferences, fostering dialogue on the latest advancements in dentistry. With a unique blend of clinical expertise and innovative thinking, Dr. Prabhuji continues to drive impactful changes in dental research and patient care.

Research Interests

Dr. Varun Prabhuji’s research interests lie at the intersection of advanced endodontics, dental biomaterials, and minimally invasive dentistry. His work is particularly focused on developing innovative dental devices and techniques that enhance precision and patient outcomes. Dr. Prabhuji is passionate about guided endodontic procedures, a field where he has contributed patented solutions like PriciGuide®. His research extends to exploring novel dental materials and their applications in restorative dentistry, with an emphasis on improving durability and biocompatibility. Another area of interest involves integrating digital technologies into clinical workflows to streamline procedures and enhance diagnostic accuracy. Through his research, Dr. Prabhuji aims to bridge the gap between scientific discovery and practical implementation, ensuring that advancements in dental science translate into tangible benefits for both clinicians and patients. His commitment to innovation is reflected in his ongoing pursuit of new methodologies to improve oral health care.

Research Skills

Dr. Varun Prabhuji possesses a diverse skill set in dental research, encompassing both experimental methodologies and technological innovation. He is proficient in advanced endodontic techniques, including guided endodontics and minimally invasive procedures. His expertise extends to the development and validation of dental biomaterials, where he applies rigorous scientific methodologies to evaluate material performance and biocompatibility. Dr. Prabhuji is also skilled in intellectual property development, with multiple patents and trademarks to his name. He has successfully secured competitive research funding, including grants from IIT Mandi and the Software Technology Park of India (STPI), reflecting his ability to translate research concepts into tangible innovations. Additionally, he is experienced in scholarly writing and has published extensively in peer-reviewed journals. His ability to integrate clinical expertise with research acumen makes him a leading figure in the field of dental innovation and an asset to the broader scientific community.

Awards and Honors

Dr. Varun Prabhuji has received numerous awards recognizing his excellence in dental research and innovation. Among his most notable honors are the IDA Colgate Scholarship and the ISP Merit Award, acknowledging his academic achievements during his undergraduate studies. He is a recipient of the Charaka Award for Excellence in Endodontics and the Young Achiever’s Award, reflecting his contributions to clinical practice and research. Internationally, Dr. Prabhuji was a finalist in the Aesthetic Dentistry MENA Awards 2024 across three categories. His innovative work has also earned him substantial research funding, including a ₹5,00,000 NIDHI PRAYAS grant from IIT Mandi and a ₹1,80,000 grant from STPI. These recognitions underscore his commitment to advancing dental science and his ability to make a significant impact in both academic and clinical domains. Dr. Prabhuji’s accolades highlight his dedication to pushing the boundaries of dental research and improving patient care.

Conclusion

Dr. Varun Prabhuji stands out as a leading figure in dental research and innovation, with a robust academic background and a track record of significant contributions to the field. His expertise spans advanced endodontics, dental biomaterials, and technological innovation, as demonstrated through his patents, research publications, and professional leadership. His ability to merge scientific research with practical applications has led to tangible advancements in dental care. Dr. Prabhuji’s commitment to community service through the Prabhuji Foundation further reflects his dedication to improving oral health beyond the laboratory. With a unique combination of clinical prowess, research innovation, and community impact, he is a deserving candidate for the Excellence in Research Award. His ongoing efforts to advance dental science while maintaining a focus on patient outcomes position him as a transformative force in the field, making a lasting impact on both academic and clinical communities.

Publication Top Notes

  1. Beyond Traditional Techniques: PriciGuide® and PriciPost® Systems – A Glimpse into the Future of Endodontics

    • Authors: Varun Prabhuji, Srirekha A, Veena Pai, Archana S
    • Year: 2025
  2. Saving the Tooth Beneath the Crown: PriciGuide® System for Guided Access Opening Through the Prosthesis

    • Authors: Varun Prabhuji, Srirekha A, Archana S, Suditi Pal
    • Year: 2025
  3. Conquering Calcification: How PriciGuide® System is Transforming Endodontics. A Case Report

    • Authors: Prabhuji Varun, Anand Pari, A Srirekha, Archana S
    • Year: 2025
  4. Comparative Evaluation of Efficacy of Guided Endodontic Technique With and Without Sleeve for Access Cavity Preparation: An In Vitro Study

    • Authors: Varun Prabhuji, S. Archana, A. Srirekha, Veena Pai, C. Champa, Ashwija Shetty
    • Year: 2024
  5. Precision in Endodontic Therapy by Novel-Guided Approach

    • Authors: Md Shabnam, Sujatha Irodi, K.B Jayalakshmi, Varun Prabhuji, Shibani Shetty, Neevika Singh
    • Year: 2024
  6. Calcified Canal Conquered: A Case Report of Minimally Invasive Management of a Calcified Maxillary Central Incisor Using the PriciGuide® System

    • Authors: Ashwija Shetty, Hajira A Sultana, Keerthan B V, Varun Prabhuji
    • Year: 2024
  7. Management of Traumatized Teeth With Severely Calcified Canals and Minimally Invasive Access Cavity Using the AReneto® System: A Case Report

    • Authors: Pucha Sai Manaswini, Varun Prabhuji, Champa C, Srirekha A, Veena S Pai
    • Year: 2024
  8. Digital Precision Meets Dentin Preservation: PriciGuide™ System for Guided Access Opening

    • Authors: Varun Prabhuji, A. Srirekha, Veena Pai, Archana Srinivasan, S. M. Laxmikanth, Shwetha Shanbhag
    • Year: 2024
  9. Device and Method for Dental Treatment Operations

    • Inventor: Varun Prabhuji
    • Year: 2023
  10. Comparative Evaluation of Efficacy of Enzymatic Toothpaste Over Standard Fluoridated Toothpaste in Reduction of Plaque and Gingivitis

    • Authors: Ashwin P S, Varun Prabhuji, Karthikeyan Bangalore Vardhan, Prabhuji MLV
    • Year: 2021

 

 

Walid Al-Zordk | Fixed Prosthodontics | Best Researcher Award

Assist Prof Dr. Walid Al-Zordk | Fixed Prosthodontics | Best Researcher Award

Assist Professor at Faculty of Dentistry, Mansoura University, Egypt.

Walid A. Al-Zordk is an Assistant Professor in the Department of Fixed Prosthodontics at the Faculty of Dentistry, Mansoura University, Egypt. He holds an MD and a Ph.D. in Fixed Prosthodontics, demonstrating a solid academic foundation and expertise in his field. With extensive teaching experience at several institutions, including Mansoura University and Horus University, he is dedicated to educating the next generation of dental professionals. Dr. Al-Zordk has completed nine research projects, contributing significantly to advancements in prosthodontics, and serves as the Managing Editor of the Mansoura Journal of Dentistry, where he promotes rigorous academic standards. His H-index of 8 reflects his scholarly impact, although there is potential for further growth in publication volume and industry collaboration. Overall, his commitment to research, teaching, and academic leadership positions him as a valuable asset to the dental community and a deserving candidate for the Best Researcher Award.

Profile:

Education

Walid A. Al-Zordk has a strong educational background in the field of dentistry, specifically specializing in Fixed Prosthodontics. He earned his Bachelor of Science in Oral and Dental Medicine from Mansoura University, Egypt. Following this foundational degree, he pursued a Master’s degree in Fixed Prosthodontics at the same institution, further enhancing his expertise in this specialized area. Dr. Al-Zordk continued his academic journey by obtaining a Ph.D. in Fixed Prosthodontics from Mansoura University, solidifying his position as a knowledgeable and skilled practitioner in the field. Throughout his educational experience, he has gained valuable insights and skills, which he has successfully applied in various academic roles, including his current position as an Assistant Professor in the Department of Fixed Prosthodontics at the Faculty of Dentistry. His comprehensive training and dedication to continuous learning underpin his commitment to advancing the field of prosthodontics and educating future dental professionals.

Professional Experience

Walid A. Al-Zordk is an accomplished professional with extensive experience in the field of Fixed Prosthodontics. He began his academic journey as a Clinical Demonstrator in the Department of Conservative Dentistry at Mansoura University, Egypt. His dedication and expertise led him to various roles, including Assistant Lecturer and Lecturer at multiple institutions, such as Delta University for Science and Technology and Horus University. Over the years, he has transitioned to positions of greater responsibility, becoming an Associate Professor at both Mansoura University and Horus University, where he imparts knowledge to aspiring dental professionals. In addition to his teaching roles, Dr. Al-Zordk serves as the Managing Editor of the Mansoura Journal of Dentistry, contributing to the advancement of dental research through editorial oversight. His professional journey reflects a strong commitment to education, research, and the development of innovative practices in the field of dentistry, making him a respected figure in the academic community.

Research Interest

Walid A. Al-Zordk’s research interests primarily focus on the field of prosthodontics, particularly in fixed prosthodontics. He is dedicated to exploring innovative approaches to enhance the quality and longevity of dental restorations, emphasizing the development of advanced materials and techniques that improve patient outcomes. His work investigates the mechanical and biological properties of various dental materials, aiming to understand their interactions within the oral environment. Additionally, Dr. Al-Zordk is keen on integrating digital technologies into prosthodontics, such as computer-aided design and manufacturing (CAD/CAM), to optimize the fabrication of dental prostheses. He also seeks to address challenges in the field, including the management of complex cases and the aesthetics of dental restorations. Through his research, Dr. Al-Zordk aims to contribute to evidence-based practices in dentistry and enhance the educational experience for future dental professionals.

Research Skills

Walid A. Al-Zordk possesses a robust set of research skills that enhance his contributions to the field of Fixed Prosthodontics. His expertise in clinical research methodologies enables him to design and execute studies effectively, ensuring the validity and reliability of his findings. Proficient in data analysis, he utilizes statistical tools to interpret complex datasets, thereby deriving meaningful conclusions that advance dental practices. His strong literature review skills allow him to critically evaluate existing research, identifying gaps and formulating relevant research questions. Furthermore, his experience in managing editorial responsibilities for the Mansoura Journal of Dentistry underscores his understanding of the peer review process and scholarly communication. Dr. Al-Zordk’s ability to collaborate with multidisciplinary teams fosters innovation and knowledge sharing, while his commitment to mentoring emerging researchers ensures the sustainability of academic excellence in prosthodontics. Collectively, these skills position him as a leader in dental research and education.

Award and Recognition

Walid A. Al-Zordk has garnered significant recognition throughout his academic career in the field of Fixed Prosthodontics. He has been acknowledged for his outstanding contributions to dental research, with several accolades highlighting his innovative work. His role as Managing Editor of the Mansoura Journal of Dentistry underscores his influence and dedication to advancing dental education and research. Al-Zordk has presented at various national and international conferences, earning praise for his presentations and fostering collaboration in the dental community. His scholarly contributions, reflected in his H-index of 8, demonstrate the impact of his research on peers and practitioners. Additionally, he is actively involved in mentoring aspiring researchers, further solidifying his reputation as a respected educator. These accomplishments affirm his commitment to excellence and innovation in dentistry, positioning him as a prominent figure in the field and deserving of recognition through prestigious awards.

Conclusion

In conclusion, Walid A. Al-Zordk stands out as a deserving candidate for the Best Researcher Award due to his solid academic foundation, notable research contributions, and leadership in academia. While there are areas for improvement, particularly in increasing his publication and consultancy engagements, his commitment to advancing the field of prosthodontics and his active role in educating future professionals make him a valuable asset to the academic community. His recognition through this award would not only honor his achievements but also inspire continued excellence in dental research and education.

Publication Top Notes

  • Computer vision based distributed denial of service attack detection for resource-limited devices
    • Authors: Gebrye, H., Wang, Y., Li, F.
    • Year: 2024
    • Journal: Computers and Electrical Engineering
    • Volume/Issue/Page: 120, 109716
  • Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide
    • Authors: El-Gizawy, S.A., Osman, M.A., Arafa, M.F., El Maghraby, G.M.
    • Year: 2015
    • Journal: International Journal of Pharmaceutics
    • Volume/Issue/Page: 478(2), 773-778
  • Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets
    • Authors: Arafa, M.F., El-Gizawy, S.A., Osman, M.A., El Maghraby, G.M.
    • Year: 2016
    • Journal: Drug Development and Industrial Pharmacy
    • Volume/Issue/Page: 42(8), 1225-1233
  • Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis
    • Authors: Eid, R.K., Ashour, D.S., Essa, E.A., El Maghraby, G.M., Arafa, M.F.
    • Year: 2020
    • Journal: Carbohydrate Polymers
    • Volume/Issue/Page: 232, 115826
  • Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets
    • Authors: Arafa, M.F., El-Gizawy, S.A., Osman, M.A., El Maghraby, G.M.
    • Year: 2018
    • Journal: Pharmaceutical Development and Technology
    • Volume/Issue/Page: 23(5), 454-463
  • Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation
    • Authors: Arafa, M.F., El-Gizawy, S.A., Osman, M.A., El Maghraby, G.M.
    • Year: 2017
    • Journal: Journal of Drug Delivery Science and Technology
    • Volume/Issue/Page: 38, 9-17
  • Microemulsion for simultaneous transdermal delivery of benzocaine and indomethacin: in vitro and in vivo evaluation
    • Authors: El Maghraby, G.M., Arafa, M.F., Osman, M.A.
    • Year: 2014
    • Journal: Drug Development and Industrial Pharmacy
    • Volume/Issue/Page: 40(12), 1637-1644
  • Lidocaine as eutectic forming drug for enhanced transdermal delivery of nonsteroidal anti-inflammatory drugs
    • Authors: Marei, H.F., Arafa, M.F., Essa, E.A., El Maghraby, G.M.
    • Year: 2021
    • Journal: Journal of Drug Delivery Science and Technology
    • Volume/Issue/Page: 61, 102338
  • Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice
    • Authors: Elmehy, D.A., Saad, M.A.H., El Maghraby, G.M., Arafa, M.F., Soliman, N.A., …
    • Year: 2021
    • Journal: Parasitology Research
    • Volume/Issue/Page: 120(7), 2641-2658
  • Liposomes for enhanced cellular uptake of anticancer agents
    • Authors: El Maghraby, G.M., Arafa, M.F.
    • Year: 2020
    • Journal: Current Drug Delivery
    • Volume/Issue/Page: 17(10), 861-873

 

 

 

DIEGO ENRICO | Medicine and Dentistry | Best Researcher Award

Dr. DIEGO ENRICO | Medicine and Dentistry | Best Researcher Award

MD at Instituto Alexander Fleming, Argentina

Dr. Diego H. Enrico is an accomplished Medical Oncologist at the Alexander Fleming Cancer Institute in Buenos Aires, Argentina. He specializes in thoracic oncology and is the Coordinator of the Cancer Research and Innovation Unit. Dr. Enrico holds an MD from the University of Morón and completed his oncology residency at Eva Perón General Hospital. He further honed his expertise through a fellowship at the Gustave Roussy Cancer Center in Paris, focusing on translational and clinical cancer research. His research contributions include multiple clinical trials and numerous awards for his work in oncology, particularly in lung and prostate cancer. Dr. Enrico has co-authored several influential studies and received prestigious grants for cancer research. In addition to his clinical and research roles, he is an experienced educator and has served as co-director of research methodology programs. His ongoing work focuses on innovative cancer therapies and improving patient outcomes.

Profile:

Education

Dr. Diego H. Enrico holds a robust academic background in both medicine and business. He earned a Bachelor’s degree in Business Administration from N° 7 Educational School in Luján, Buenos Aires, graduating Summa Cum Laude in 2002 with an impressive 9.9/10 GPA. Pursuing his passion for healthcare, Dr. Enrico then attended the University of Morón School of Medicine, where he completed his MD degree in 2013, graduating Cum Laude with a GPA of 8.89/10. He further specialized in Medical Oncology through a postgraduate degree from the University of Buenos Aires between 2013 and 2015. Dr. Enrico has enhanced his expertise in clinical oncology with advanced studies abroad, completing the European University Diploma in Translational and Clinical Cancer Research and the University Diploma of Clinical Oncology at Université Paris XI, France, in 2019. His international training underscores his dedication to improving cancer research and patient care.

Professional Experiences 

Dr. Diego H. Enrico is a distinguished Medical Oncologist at the Alexander Fleming Cancer Institute in Buenos Aires, Argentina. Since June 2021, he has been an integral part of the Thoracic Oncology Unit, and in June 2022, he also joined the Clinical Research Unit. Dr. Enrico serves as the Coordinator of the Cancer Research and Innovation Unit (ETIC), a role he has held since March 2021. He has extensive experience in both clinical practice and research, specializing in thoracic oncology and leading innovative cancer research projects. Dr. Enrico has also contributed significantly to clinical trials, serving as a sub-investigator in multiple studies focusing on novel treatments for non-small cell lung cancer. His career is further highlighted by his previous fellowship at the prestigious Gustave Roussy Cancer Center in Paris, France, where he worked on translational and clinical research, particularly in thoracic oncology and drug development.

Research Interests

Dr. Diego H. Enrico’s research interests are centered around clinical oncology, with a particular focus on thoracic oncology and innovative cancer treatments. His work delves into the development of targeted therapies for non-small cell lung cancer (NSCLC), emphasizing the genetic and molecular underpinnings of the disease, such as EGFR mutations and KRAS mutations. Dr. Enrico actively participates in clinical trials, contributing to the advancement of combination therapies and immunotherapy strategies, including the use of novel agents like amivantamab, nivolumab, and pembrolizumab. He is also dedicated to improving patient outcomes through translational research, bridging the gap between laboratory findings and clinical applications. Additionally, Dr. Enrico’s interests include investigating biomarkers for cancer prognosis and the evaluation of treatment responses, as well as optimizing the safety and efficacy of cancer therapies through remote monitoring systems and real-life studies in oncology. His contributions significantly impact the field of precision medicine and personalized cancer care.

Research Skills

Dr. Diego H. Enrico possesses a broad range of research skills, particularly in the field of clinical oncology, with a strong focus on thoracic oncology. His expertise includes designing and conducting clinical trials, with experience in Phase I, II, and III trials for advanced malignancies and targeted therapies. As the Coordinator of the Cancer Research and Innovation Unit at the Alexander Fleming Cancer Institute, he has honed his abilities in translational cancer research, contributing to numerous studies on innovative treatments for non-small cell lung cancer. His proficiency in biostatistics, clinical research methodology, and the use of patient-reported outcomes to improve therapy adherence further highlights his analytical and strategic thinking. Additionally, Dr. Enrico has received several prestigious awards for his scientific contributions and has successfully led collaborative projects funded by international grants. His deep understanding of oncological biomarkers and personalized medicine makes him a leading researcher in the oncology field.

Award And Recognition 

Dr. Diego H. Enrico, a distinguished medical oncologist, has garnered numerous accolades throughout his career, highlighting his significant contributions to oncology. He has received multiple “Best Scientific Work” awards at prestigious conferences such as the XLIII and XLII Argentine Association of Clinical Oncology Post-Chicago Meeting and Update (2023, 2022) for his groundbreaking research in targeted therapy for lung cancer and prostate cancer treatments. Dr. Enrico was also honored at the First National Congress on Oncology for his work on adverse effects in clinical trials (2020) and has received several best poster awards for his research on prognostic factors in liver metastases and breast cancer. Additionally, his work in clinical research ethics earned him recognition from the Jaime Roca Foundation with the Annual Bioethics Award in 2018. Dr. Enrico’s achievements underscore his expertise and dedication to advancing cancer treatment and clinical research globally.

Conclusion

Dr. Diego H. Enrico is a strong candidate for the Best Researcher Award, particularly due to his significant contributions to thoracic oncology research, his leadership in clinical innovation, and his consistent recognition through awards. Strengthening his international presence and expanding his research focus could further elevate his profile as a leading researcher in the global oncology community.

Publication Top Notes
  • “Manifestations of Exile and Diaspora in the Poetry of Abdullah al-Baradouni”
  • “The Educational Technology’s Impact on Youth Creativity and Innovation: A Case of Ha’il Region of Saudi Arabia”
    • Authors: Harman Preet Singh; Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2023
    • Source: Revista Amazonia Investiga
    • DOI: 10.34069/AI/2023.66.06.14
  • “The Impact of Globalization on Culture and Identity with Reference to Selected Works by Taha Hussein”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2022
    • Source: Addaiyan Journal of Arts, Humanities and Social Sciences
  • “City Literature in Abdu al-Aziz al-Makkali’s Poetry”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2021
    • Source: International Journal of Comparative Literature & Translation Studies
  • “Sociology and Literature: An Interdisciplinary Approach”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2020
    • Source: Journal of Liberal Arts and Humanities
  • “A Sociological Study of Some Selected Poems by Hatim Altai”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2020
    • Source: International Review of Humanities and Scientific Studies
  • “Literary Discourse and Human Rights in Martin Luther King’s Speech: I Have a Dream”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2019
    • Source: Studies in Literature and Language
  • “The Allegorical Structure in Animal Farm”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2019
    • Source: Al-Yemenia University

 

Claudia Von Arx | Medicine and Dentistry | Best Researcher Award

Dr. Claudia Von Arx | Medicine and Dentistry | Best Researcher Award

Oncology consultant/Researcher of INT IRCCS Fondazione G. Pascale, Italy.

Claudia Von Arx is a dedicated researcher and medical professional with a wealth of experience in oncology research. She completed her medical degree at the University of Naples “Federico II” and subsequently specialized in Medical Oncology. Claudia pursued her passion for research by undertaking a PhD at Imperial College London, focusing on the development of recombinant OPCML tumor suppressor protein as a therapy for ovarian cancer. With extensive experience as a clinical research fellow at prestigious institutions like Imperial College London and INT IRCSS Fondazione G. Pascale of Naples, Claudia has contributed significantly to preclinical and translational research in oncology. Her expertise lies in developing predictive biomarkers, planning and conducting clinical trials, and exploring innovative treatment strategies for various types of cancer. Claudia’s commitment to advancing cancer research and patient care underscores her dedication to improving outcomes in oncology.

Professional Profiles:

Education

Ali Gholizadeh pursued his academic journey with distinction, attaining a Master of Science (2) in Material and Surface Engineering from École Nationale Supérieure d’Arts et Métiers (ENSAM) in 2020. Prior to this, he completed a Master of Science (1) in Mechanical Engineering, with a focus on Fluid Dynamics, also from ENSAM, in 2018. Ali’s educational foundation was laid with a Bachelor of Science in Mechanical Engineering from Shahid Bahonar University of Kerman in 2017. Throughout his academic career, Ali demonstrated exceptional aptitude and dedication, evidenced by his research projects and academic achievements.

Professional Experience

Ali Gholizadeh is an accomplished engineer with a diverse background in research and development. Currently serving as a Research Engineer at the University of Liège, he specializes in the development of innovative chip architectures for biochemical workflows. With previous roles at Fluigent and the Science and Technology Research Center, Ali has honed his skills in microfluidic technologies, CAD design, and data analysis. His academic journey includes a Master’s degree in Material and Surface Engineering from École Nationale Supérieure d’Arts et Métiers and a Bachelor’s degree in Mechanical Engineering from Shahid Bahonar University of Kerman. Throughout his career, Ali has demonstrated a strong commitment to advancing engineering solutions through cutting-edge research and development initiatives.

Research Interest

Ali Gholizadeh’s research interests encompass several areas of engineering, with a primary focus on microfluidic technologies and their applications. He is particularly interested in the design and optimization of microfluidic chips for various biochemical workflows, including sample preparation, analysis, and diagnostics. Additionally, Ali is passionate about exploring novel materials and fabrication techniques to enhance the performance and functionality of microfluidic devices. His research also extends to areas such as lab-on-a-chip systems, high-speed imaging, and instrument interface development. Overall, Ali’s goal is to contribute to the advancement of interdisciplinary research at the intersection of engineering, biology, and medicine, with the ultimate aim of addressing real-world challenges and improving human health.

Award and Honors

Ali Gholizadeh has received several honors and awards in recognition of his contributions to research and academia. Notably, he was selected as a ranked student for participation in a prestigious dual degree program between IUST and ENSAM, where his master’s project received the highest score by the jury. Additionally, he achieved the top 1% rank among 35,000 participants in the nationwide university entrance exam for graduate studies in Mechanical Engineering, earning a full scholarship to study at IUST. These accomplishments highlight Ali’s academic excellence and dedication to his field, positioning him as a promising young researcher in the engineering community.

Research Skills

Ali Gholizadeh possesses a diverse set of research skills that enable him to excel in his field. His expertise includes design and microfabrication of electromechanical instruments and microfluidic chips, along with proficiency in CAD, 3D printing, and software programming for development purposes. He is skilled in data analysis and post-processing, utilizing tools such as MATLAB, Python, and image processing techniques. Additionally, Ali has experience in high-speed imaging and microscopy, contributing to his ability to conduct detailed analysis and observation in his research projects. His critical thinking, problem-solving abilities, and strong teamwork skills further enhance his research capabilities, allowing him to make significant contributions to the advancement of engineering and technology.

Publications

  1. A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial
    • Authors: C. von Arx, G. Della Vittoria Scarpati, L. Cannella, A. Ottaiano, S. Tafuto
    • Journal: ESMO Open
    • Year: 2024
    • Volume: 9
    • Issue: 5
    • Citations: 0
  2. Cancer genetic counselling for hereditary breast cancer in the era of precision oncology
    • Authors: M. Pensabene, A. Calabrese, C. von Arx, R. Caputo, M. De Laurentiis
    • Journal: Cancer Treatment Reviews
    • Year: 2024
    • Volume: 125
    • Citations: 0
  3. Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion
    • Authors: R. Caputo, G. Buono, V.D. Lauro, F. Nuzzo, M. De Laurentiis
    • Journal: Future Oncology
    • Year: 2023
    • Volume: 19
    • Issue: 24
    • Pages: 1695–1708
    • Citations: 0
  4. The Complex Management of the Breast Angiosarcoma: A Retrospective Study
    • Authors: L. Cannella, F. Perri, O. Clemente, A. De Chiara, S. Tafuto
    • Journal: Oncology (Switzerland)
    • Year: 2023
    • Volume: 101
    • Issue: 4
    • Pages: 234–239
    • Citations: 1
  5. The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer
    • Authors: C. von Arx, P. De Placido, A. Caltavituro, M. Giuliano, L. Del Mastro
    • Journal: Cancer Treatment Reviews
    • Year: 2023
    • Volume: 113
    • Citations: 17
  6. Male Breast Cancer: From Molecular Genetics to Clinical Management
    • Authors: M. Pensabene, C. Von Arx, M. De Laurentiis
    • Journal: Cancers
    • Year: 2022
    • Volume: 14
    • Issue: 8
    • Pages: 2006
    • Citations: 10
  7. Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives
    • Authors: A. Ottaiano, M. Berretta, C. Von Arx, M. Capozzi, M. Caraglia
    • Journal: Frontiers in Oncology
    • Year: 2022
    • Volume: 12
    • Pages: 852445
    • Citations: 1
  8. Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)
    • Authors: I.M. Modlin, M. Kidd, K. Oberg, I.A. Drozdov, A. Kitz
    • Journal: Annals of Surgical Oncology
    • Year: 2021
    • Volume: 28
    • Issue: 12
    • Pages: 7506–7517
    • Citations: 24
  9. Selinexor and the selective inhibition of nuclear export: A new perspective on the treatment of sarcomas and other solid and non-solid tumors
    • Authors: A.L. Marretta, G. Di Lorenzo, D. Ribera, A. Pizzolorusso, S. Tafuto
    • Journal: Pharmaceutics
    • Year: 2021
    • Volume: 13
    • Issue: 9
    • Pages: 1522
    • Citations: 2
  10. Uptake of trastuzumab biosimilars for the treatment of HER2-positive breast cancer: A real-world experience from a cancer center
    • Authors: M. Piezzo, R. D’aniello, I. Avallone, M. De Laurentiis, P. Maiolino
    • Journal: Pharmaceutics
    • Year: 2021
    • Volume: 13
    • Issue: 5
    • Pages: 684
    • Citations: 3